Sinonasal Tumors: Clinical and Morphological Characteristics and Differential Diagnosis-Reference-Cited by-同舟云学术

Sinonasal Tumors: Clinical and Morphological Characteristics and Differential Diagnosis

Published:2024-08-23 Issue:3 Volume: Page:70-78
ISSN:2541-9897
Container-title:Innovative Medicine of Kuban
language:
Short-container-title:Innovacionnaâ medicina Kubani

Author:

Prokhorova A. I.¹^ORCID,Samoylova S. I.²^ORCID,Levendyuk O. A.¹^ORCID,Didenko M. I.¹^ORCID,Reshetov I. V.³,Sukortseva N. S.³^ORCID,Samoilova O. V.³^ORCID,Demura T. A.³^ORCID

Affiliation:

1. Central Clinical Hospital “Russian Railways-Medicine”

2. I.M. Sechenov First Moscow State Medical University; Central Clinical Hospital “Russian Railways-Medicine”

3. I.M. Sechenov First Moscow State Medical University

Abstract

Malignant sinonasal tumors are rare and account for 1% of all neoplasms. Most of these carcinomas are poorly differentiated or undifferentiated tumors. Due to overlapping features, both young and experienced physicians encounter difficulties in their diagnosis. We present 2 cases of 2 tumors of the sinonasal tract, which belong to small round blue cell tumors: sinonasal small cell neuroendocrine tumor and esthesioneuroblastoma.

Publisher

Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1

Reference38 articles.

1. Bracigliano A, Tatangelo F, Perri F, et al. Malignant sinonasal tumors: update on histological and clinical management. Curr Oncol. 2021;28(4):2420–2438. PMID: 34287240. PMCID: PMC8293118. https://doi.org/10.3390/curroncol28040222

2. Trieu V, Aulet RM, Ciolino A, Rimash T. SMARCB1-deficient sinonasal carcinoma: a case report and discussion of the clinical implications. Ann Otol Rhinol Laryngol. 2019;128(7):676–680. PMID: 30873845. https://doi.org/10.1177/0003489419836668

3. Shaverdashvili K, Azimi-Nekoo E, Cohen P, et al. INI1 (SMARCB1)-deficient undifferentiated sinonasal carcinoma: novel paradigm of molecular testing in the diagnosis and management of sinonasal malignancies. Oncologist. 2020;25(9):738–744. PMID: 32337786. PMCID: PMC7485347. https://doi.org/10.1634/theoncologist.2019-0830

4. Parsel SM, Jawad BA, McCoul ED. SMARCB1-deficient sinonasal carcinoma: systematic review and case report. World Neurosurg. 2020;136:305–310. PMID: 32001406. https://doi.org/10.1016/j.wneu.2020.01.130

5. Bell D, Hanna EY, Agaimy A, Weissferdt A. Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience. Virchows Arch. 2015;467(6):649–656. PMID: 26407663. https://doi.org/10.1007/s00428-015-1853-1